Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-28

FDA Approved: RANOLAZINE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved Actavis Pharma, Inc.'s original ANDA for ranolazine, a generic oral therapy for chronic angina. This approval makes a generic version of ranola…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)